Imagion Biosystems President and CEO Bob Proulx was interviewed today by Health Professional Radio, a media network dedicated to promoting awareness on healthcare issues. In his interview of Mr. Proulx, Henry Acosta of Health Professional Radio draws out descriptions of the key elements of Imagion Biosystems’ MagSense® cancer detection technology, the company’s commercialization plan, and what motivates Mr. Proulx and the company’s employees, collaborators, and investors to get MagSense® technology into hospitals and medical clinics just as soon as possible.
Listen to the eight-minute audio file here:
Positive Results from IBI10103 Phase I Study with MagSense® HER2 Imaging Agent
December 7, 2023
Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent Imagion Biosystems Limited